Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2024-11-19 00:00:00 ET · period of report 2024-11-15 · accession 0001104659-24-120670 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-19 | 2024-11-15 | PTGX | MOLINA ARTURO MD | Chief Medical Off | S - Sale | $40.98 | -1,906 | 46.4K | -4% | -$78.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-15 | S | D | 1,906 | $40.98 | 46,444 | D | — | — | (F1) Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units. |